The Harvard T.H. Chan professor, who studies supplements and health, looks at the claims made for synthetic peptides and whether they hold up.
Recap by typeshit. Post by Facebook on Facebook.
A Williamsburg shop sells injectable peptide vials for around $95 each, while the FDA has sent warning letters to sellers relying on the same label.
9:07
The endocrinologist takes on whether people can get retatrutide now, setting gray market supply against the results from Lilly's actual trials.
UW Medicine notes that many of these experimental peptides have not been regulated by the FDA, and some have never been tested in people.
Dr Bajekal flags that people on Mounjaro, semaglutide or Wegovy should talk it through with their doctor ahead of an operation.
Health records from 131 million adults linked GLP-1s to fewer dialysis or transplant cases. The researchers stress the study is observational and can't prove cause.
Lilly reports on Oct. 29, and Zacks expects investors to focus on Foundayo after the oral GLP-1 brought in $98 million in its first full quarter on sale.
Loading…